Fact-checked by Grok 2 weeks ago

Microcephaly

Microcephaly is a rare neurological characterized by an abnormally small head size, where the has not developed properly during or has stopped growing after birth, resulting in a head more than two standard deviations below the mean for , sex, and ethnicity. The condition can range from mild, where individuals may have normal intelligence and lifespan, to severe, which often leads to profound , developmental delays, and life-threatening complications. It affects approximately 1 in 1,150 babies born in the United States, though global incidence varies based on environmental and genetic factors. The primary causes of microcephaly are diverse and often multifactorial, including prenatal infections such as , , , or , which can disrupt fetal brain development. Genetic conditions like or other chromosomal abnormalities, as well as —a premature fusion of skull bones—can also lead to restricted brain growth. Environmental risk factors during pregnancy, such as maternal , uncontrolled phenylketonuria (PKU), exposure to , , or harmful substances, and complications like severe or reduced blood supply to the , further contribute to the disorder. In many cases, the exact cause remains unknown, highlighting the complexity of brain development. Symptoms of microcephaly typically manifest as a noticeably smaller head at birth or become evident during routine well-baby examinations, often accompanied by a in severe instances. Affected individuals may experience a range of neurological and developmental issues, including seizures, poor coordination and balance, feeding difficulties, or hearing impairments, and significant delays in motor skills, speech, and cognitive function. Complications can extend to facial distortions, hyperactivity, and increased susceptibility to infections, with outcomes varying widely based on the underlying cause and severity. Diagnosis involves measuring head circumference using standardized growth charts from the CDC or WHO, often starting prenatally via in the late second or early third , and confirmed postnatally through physical exams and family history review. Additional tests, such as MRI, scans, or genetic blood work, may be used to identify specific causes, particularly if developmental delays are observed. There is no cure for microcephaly, and focuses on managing symptoms and supporting through early programs, including physical, occupational, and speech therapies. In cases linked to , surgery may help relieve pressure on the , while medications can control seizures or other complications. Prevention strategies emphasize avoiding infections like Zika during , maintaining proper , and abstaining from and drugs.

Clinical Presentation

Signs and Symptoms

Microcephaly is defined as an occipitofrontal head circumference () more than two standard deviations below the mean for gestational age, sex, and population standards at birth or during postnatal development. The primary observable sign is a significantly reduced head size, which is typically measured using standardized growth charts such as those from the CDC or WHO to compare against age- and sex-matched norms. In addition to the small head, affected individuals may exhibit associated physical features, particularly in severe cases, including facial dysmorphisms such as a sloping forehead, prominent or , and an underdeveloped jaw (micrognathia). These features contribute to a distinctive appearance but vary widely among cases. Developmental symptoms are common and often profound, encompassing , delayed motor milestones (such as inability to sit unsupported by 8 months or walk independently by 18 months), seizures, and impairments in or hearing. Affected children may also experience feeding difficulties, poor coordination and balance, and hyperactivity. The presentation varies by severity: mild microcephaly (OFC between 2 and 3 standard deviations below the mean) may involve only subtle developmental delays with relatively preserved function, whereas severe cases (more than 3 standard deviations below the mean) are associated with profound and multiple physical challenges. Age-specific manifestations differ, with neonatal presentations typically showing a small head at birth detectable via routine measurements, while symptoms in infancy and early childhood emerge progressively as delays in achieving milestones become evident.

Diagnosis

Diagnosis of microcephaly relies on standardized measurements of head circumference, typically using growth charts from the (WHO) or Centers for Disease Control and Prevention (CDC). Primary microcephaly is generally confirmed when the occipitofrontal circumference (OFC) is more than 2 standard deviations (SD) below the mean for gestational age, sex, and ethnicity at birth, while severe cases are defined as more than 3 SD below the mean. Serial postnatal measurements are essential to distinguish primary microcephaly, where the head size tracks along a lower growth curve, from secondary microcephaly, where the OFC progressively falls off the growth curve due to postnatal insults. Prenatal diagnosis is often suspected through fetal , which measures biparietal diameter or head circumference that is reduced by at least 2 below the mean for , prompting further evaluation. (MRI) of the fetus may be employed to confirm anomalies, such as simplified gyral patterns or reduced volume, providing additional diagnostic clarity when ultrasound findings are equivocal. Postnatally, evaluation includes thorough , serial measurements, and with computed tomography () or MRI to assess brain structure, volume, and cortical malformations. , such as chromosomal microarray analysis () or whole-exome sequencing (WES), is recommended to identify underlying genetic causes, particularly in cases without evident environmental exposures. Differential diagnosis involves distinguishing microcephaly from conditions like , which causes abnormal head shape due to premature skull suture fusion, through clinical examination and skull radiographs or . Nutritional deficiencies or metabolic disorders, such as or organic acidemias, are ruled out via laboratory tests including serum electrolytes, thyroid function, and metabolic screening. A multidisciplinary approach, involving pediatricians, neurologists, and geneticists, ensures comprehensive , including history review and targeted investigations based on clinical suspicion. Challenges in diagnosis include variability in head shape, which can affect accurate measurement, and ethnic differences in normative head circumference, where applying WHO standards may lead to of microcephaly in certain populations like those of or some Asian descent.

Etiology

Genetic Causes

Microcephaly can arise from genetic factors, including inherited mutations and de novo variants that disrupt normal brain development during fetal growth. Primary microcephaly, also known as autosomal recessive primary microcephaly (MCPH), represents a non-syndromic form characterized by reduced head circumference at birth and intellectual disability without additional malformations. This condition is primarily caused by biallelic mutations in genes that regulate neurogenesis, particularly those involved in centrosome integrity and cell division. Key genes associated with primary microcephaly include MCPH1 (encoding microcephalin), WDR62 (MCPH2 locus), and ASPM (MCPH5 locus). Mutations in ASPM are the most frequent, accounting for approximately 50-70% of cases, while WDR62 variants contribute to 15-20%, and MCPH1 to about 8%. These genes encode proteins localized to the and mitotic spindle, essential for proper progression in neuronal progenitors. Over 30 genes have been implicated in MCPH, with pathogenic variants in more than 100 genes reported across primary forms. Recent studies as of 2025 have identified additional genes, such as EXOSC10, CDK4, and CETN3, further expanding the of primary microcephaly. Syndromic forms of genetic microcephaly occur in association with multisystem disorders, such as and Rubinstein-Taybi syndrome. , characterized by severe , proportionate , and a bird-like facial appearance, results from mutations in genes like ATR, which is involved in DNA damage response and . Rubinstein-Taybi syndrome features microcephaly alongside broad thumbs and toes, distinctive facial traits, and , primarily due to heterozygous mutations in CREBBP or , which encode histone acetyltransferases critical for . These syndromes highlight how genetic disruptions beyond isolated brain development can manifest with microcephaly as a prominent feature. De novo mutations, occurring spontaneously in the affected individual rather than inherited, play a significant role in sporadic cases of microcephaly, particularly in dominant or X-linked forms. Next-generation sequencing has identified such variants in genes like POGZ and ASXL3, leading to severe developmental delay and microcephaly without family history. These mutations are increasingly detected in cohorts where traditional linkage analysis is not feasible, aiding in non-consanguineous families. Inheritance patterns for primary microcephaly are predominantly autosomal recessive, with higher prevalence in consanguineous populations due to increased homozygosity. In Pakistani families, where rates exceed 60%, mutations in MCPH genes like ASPM and WDR62 are notably common, contributing to carrier frequencies that elevate risk in these groups. Autosomal dominant forms, though rarer, have been reported but do not involve WDR62. Genetic causes account for approximately 25-30% of isolated microcephaly cases, with primary forms comprising a where no other anomalies are present. This proportion varies by population and diagnostic methods, but underscores the importance of in determination. At the molecular level, mutations in MCPH genes disrupt function and mitotic orientation, leading to premature neuronal and reduced progenitor . For instance, ASPM variants impair spindle pole organization, causing asymmetric divisions that deplete the neuronal progenitor pool. Similarly, WDR62 mutations affect microtubule and centrosomal attachment to the , resulting in disorganized cortical layering and smaller . These defects primarily occur during early , highlighting the sensitivity of expansion to genetic perturbations in machinery.

Environmental and Infectious Causes

Environmental and infectious causes of microcephaly encompass a range of prenatal, perinatal, and postnatal exposures that disrupt fetal or brain development, leading to reduced head circumference and impaired neuronal growth. These factors are distinct from genetic etiologies and often involve modifiable risks such as maternal substance use or preventable infections. Teratogenic exposures during critical periods of can interfere with neural and , resulting in congenital microcephaly. Maternal alcohol consumption during pregnancy is a well-established teratogen associated with fetal alcohol spectrum disorders (FASD), which frequently include microcephaly as a hallmark feature due to disrupted brain volume and head growth. Prenatal alcohol exposure has been shown to increase the rates of microcephaly, with affected children exhibiting smaller head circumferences compared to unexposed peers. Similarly, maternal tobacco smoking during pregnancy is linked to reduced fetal head circumference and an elevated risk of congenital microcephaly, likely through vascular effects and nicotine-induced growth restriction. Ionizing radiation exposure in utero, particularly during the first trimester, is a potent teratogen that commonly causes microcephaly, as evidenced by historical cohorts from atomic bomb survivors and medical imaging studies, where doses above 50 mGy significantly impair brain development. Antiepileptic drugs like valproic acid, when used in early pregnancy, heighten the risk of fetal microcephaly and craniofacial dysmorphisms by altering neural tube closure and progenitor cell function. Nutritional deficiencies in the mother or infant can also precipitate microcephaly by hindering essential processes like and myelination. Severe maternal during pregnancy leads to endemic cretinism, characterized by microcephaly and irreversible neurological impairment, with studies showing a reduction in microcephaly rates from 27% to 11% following iodine supplementation in deficient populations. in utero has been associated with microcephaly alongside defects, as inadequate folate impairs and cerebral folate transport, contributing to abnormal brain morphogenesis. Infectious agents represent a major category of acquired causes, particularly congenital infections that cross the and target developing neural tissues. The complex—encompassing , other agents (, varicella-zoster, ), , (CMV), and —is a primary culprit, with CMV being the most frequent, where microcephaly occurs in up to 20% of symptomatic congenital CMV cases, through direct viral cytopathy in neural progenitors. , an , gained prominence for inducing severe microcephaly during the 2015-2016 outbreaks, where maternal infection interfered with cortical development, leading to head circumferences reduced by over 3 standard deviations in affected infants. Other es, such as , have been linked to congenital microcephaly in case reports from endemic regions, with maternal infection during pregnancy correlating with smaller head sizes at birth. Hypoxic-ischemic events, including and , can result in acquired microcephaly by compromising oxygen delivery to the fetal , leading to neuronal loss and volume reduction. , such as or , has been associated with increased microcephaly risk, as these disrupt nutrient and oxygen transfer during . Postnatal causes primarily arise from environmental toxins or metabolic disruptions in early infancy. Severe after birth can stunt head growth, contributing to progressive microcephaly, especially in resource-limited settings where caloric and nutrient deficits persist. in young children impairs neurodevelopment and has been implicated in reduced volume, potentially leading to microcephaly-like features through heavy metal toxicity. Untreated , if not screened and managed early, results in microcephaly due to deficiency affecting maturation. Certain risk factors amplify susceptibility to these causes. over 35 years may slightly elevate microcephaly risk through increased chromosomal instability or vascular complications, though evidence is mixed. Lower correlates with higher incidence, driven by limited access to , higher exposure to infections like Zika, and nutritional inadequacies, with studies showing up to 30% greater odds in low-education households. Geographic hotspots, such as during Zika epidemics, highlight how vector-borne diseases exacerbate risks in vulnerable populations. The link between and microcephaly was formally recognized in historical context following the outbreak in , where cases surged dramatically; the declared it a Public Health Emergency of International Concern in February 2016, prompting global surveillance and research into prevention. This event underscored the role of emerging infections in non-genetic microcephaly etiologies.

Pathophysiology

Mechanisms of Brain Development Impairment

Microcephaly arises from disruptions in the early phases of , particularly during the proliferation of neural stem cells in the ventricular zone between gestational weeks 8 and 24, when the expands rapidly. This period is critical for generating the neuronal progenitor pool, and impairments lead to a depleted of neural , resulting in fewer neurons overall. Key cellular processes affected include the balance between symmetric and asymmetric cell divisions of neural progenitors, which normally expands the progenitor pool while producing differentiated neurons; in microcephaly, this balance shifts toward depletion, yielding a smaller . Additionally, dysregulation of contributes to excessive neuronal loss, further reducing cortical volume. These disruptions culminate in structural abnormalities such as simplified gyral patterns, including or agyria, diminished , and , which are detectable via MRI and reflect the underlying failure in cortical layering and expansion. Across diverse etiologies, these impairments converge on common pathways involving dynamics and integrity, which are essential for proper assembly and segregation during . For instance, genetic , environmental toxins, or viral infections like Zika—where the NS5 protein localizes to centrosomes and inhibits progression—prolong and activate surveillance mechanisms that trigger death, independent of the specific cause. Prenatal insults during this gestational window are most severe, as they coincide with peak cortical , whereas postnatal disruptions typically result in milder, secondary effects on brain growth. Insights from animal models, such as knockouts of genes implicated in microcephaly, demonstrate these mechanisms through significant reductions of 30-50%, mirroring the progenitor depletion and cortical thinning observed in humans. These models highlight how early embryonic disruptions in and survival propagate to lifelong neurodevelopmental deficits.

Associated Neurological Features

Microcephaly is frequently accompanied by cortical malformations such as , characterized by a smooth brain surface due to disrupted neuronal migration, and , involving excessive small gyri that impair cortical connectivity and cognitive function. These anomalies arise from defects in or neuronal organization, leading to disorganized layering and reduced functional integration across brain regions. Cerebellar and brainstem are common secondary features, often resulting in impaired and difficulties with feeding due to disrupted reflexes and postural control. In conditions like microcephaly with pontine and , these structural deficits manifest as and oral-motor incoordination, exacerbating early developmental challenges. White matter abnormalities, including and , further contribute to neurological compromise by reducing myelinated tracts and causing compression of adjacent tissue from enlarged ventricles. These changes, observed in both infectious and genetic forms, lead to diminished signal transmission and increased susceptibility to injury. Functionally, up to 40% of individuals with microcephaly experience , often with characteristic EEG patterns such as in infantile spasms, alongside from involvement and disorders affecting integration of visual or auditory inputs. typically presents as mild to moderate , while sensory issues contribute to behavioral and adaptive deficits. The associated features exhibit significant heterogeneity depending on etiology; for instance, congenital cytomegalovirus infections often involve intracranial calcifications and white matter hyperintensities, whereas genetic forms like autosomal recessive primary microcephaly feature a thin cortex with simplified gyral patterns. This variation underscores the diverse impacts on brain architecture across causes. Advanced imaging techniques, such as diffusion tensor imaging, reveal altered neural tracts in microcephaly, showing reduced fractional anisotropy and disrupted fiber integrity in white matter pathways like the corpus callosum. These findings, detectable via MRI, highlight microstructural deficits beyond gross anatomy.

Management and Prognosis

Treatment Approaches

There is no cure for microcephaly, and treatment focuses on symptomatic and supportive management to address associated complications and optimize rather than reversing the underlying brain size reduction. Management is tailored to the severity and , emphasizing early detection of comorbidities such as seizures, developmental delays, and motor impairments. Pharmacological interventions primarily target seizure control, as epilepsy affects a significant proportion of individuals with microcephaly, particularly in congenital Zika virus-associated cases where up to 86% may require antiepileptic drugs (AEDs). is commonly used as an adjunctive in pediatric refractory epilepsy, including in children with microcephaly, due to its favorable safety profile and efficacy in reducing frequency by at least 50% in over 50% of cases with partial . has been trialed in select cases of mild, sporadic primary microcephaly with associated , showing improved linear growth and head circumference in small cohorts, though evidence remains limited to case series without broad clinical endorsement. In neonates with microcephaly linked to congenital infections or metabolic issues, treatment of hyperbilirubinemia via intensive phototherapy or is essential to prevent kernicterus-related neurological worsening. Surgical options are reserved for specific complications; ventriculoperitoneal shunt placement may be indicated in rare instances of co-occurring , as seen in the "microcephalic hydrocephalus" paradox where excess accumulation exacerbates despite small head size. For severe craniofacial dysmorphisms, such as those in syndromic microcephaly with , reconstructive craniofacial surgery can alleviate functional issues like airway obstruction or elevated . Emerging therapies for monogenic forms, such as those involving MCPH1 mutations, include preclinical gene editing research using CRISPR-Cas9 in induced pluripotent -derived brain organoids, which recapitulate microcephaly phenotypes and suggest potential for correcting neural progenitor defects, though no clinical trials are available as of 2025. approaches, including neural progenitor transplantation to promote , remain in preclinical stages, with studies demonstrating disrupted in microcephaly models but lacking trial data. A multidisciplinary team approach is central, involving to enhance motor skills, for daily functioning, and speech therapy to support communication in cases of cognitive and developmental delays. The (AAP) recommends immediate referral to early programs for children with microcephaly to maximize neurodevelopmental outcomes through coordinated therapies. The (WHO) endorses similar early strategies within broader congenital management frameworks to address long-term disabilities.

Long-term Outcomes

The long-term developmental outcomes for individuals with microcephaly vary widely depending on the severity and underlying , but is a common feature across cases. In milder forms, such as certain genetic primary microcephaly, full-scale IQ scores typically range from 40 to 70, with an average around 52, allowing for some functional abilities despite delays. Severe cases, particularly those associated with congenital infections, often result in profound , with standardized scores at or near the floor of 55 and developmental ages equivalent to 2-4 months by age 2-3 years. Most individuals require lifelong support for daily activities, as microcephaly is a permanent without curative , though a minority with isolated mild microcephaly may achieve near-normal cognitive function. Comorbidities significantly influence prognosis, with increased risks of neurological issues such as (affecting up to 81% in some cohorts), visual impairments (moderate to severe in about 48%), and behavioral challenges including traits and stereotypic behaviors. Early mortality is elevated, particularly from complications like due to and poor protective reflexes, which are prevalent in severe congenital forms. Quality of life is impacted by the need for educational accommodations, such as individualized learning plans to address cognitive and motor delays, and substantial employment challenges, with most adults facing limited independence due to . burden is high, with caregivers reporting drastic life changes, anxiety, and reduced personal from ongoing care demands. Early therapies have shown potential to mitigate some effects, improving neurodevelopmental trajectories and alleviating through better outcomes. Outcomes differ markedly by , with congenital microcephaly—especially from intrauterine infections like Zika—linked to more profound and lower independence compared to postnatal acquired forms, where prompt treatment of causes (e.g., metabolic disorders) can yield better . In Zika-related cases, nearly all children exhibit severe impairments across domains. Longitudinal studies, such as the Microcephaly Epidemic Research Group Paediatric following over 700 children for up to several years, indicate variable progress, with 20-40% achieving partial independence in basic depending on early comorbidities and support. Recent research highlights in young children with microcephaly, suggesting targeted cognitive stimulation and intensive therapies may foster modest gains in developmental skills, particularly in receptive language and motor function.

Epidemiology and History

Prevalence and Risk Factors

Microcephaly occurs globally with a baseline prevalence estimated at 2 to 12 cases per 10,000 live births, though rates vary significantly by region and population characteristics. In high-income countries like the and , prevalence typically ranges from 1.5 to 8.7 per 10,000 live births, while in low-resource settings, rates can be higher due to limited and higher burdens of infectious diseases. For instance, during non-epidemic periods in , prevalence has been reported at approximately 4.4 per 10,000 live births. In consanguineous populations, such as those in parts of and the , the prevalence of genetic forms of microcephaly is elevated, reaching up to 1 in 10,000 births compared to lower rates in non-consanguineous groups. This increase is attributed to autosomal recessive inheritance patterns, with conferring an of 3.1 for neural-only microcephaly. Epidemiological trends show stability in baseline genetic cases over time, but infectious outbreaks have caused temporary spikes; notably, during the 2015–2016 epidemic in , prevalence surged to 1.5 to 5 cases per 1,000 live births in affected regions like Paraíba state. Key modifiable risk factors include maternal infections, particularly , where seroprevalence during pregnancy correlates with elevated microcephaly rates. increases risk for recessive genetic forms with odds ratios ranging from 2 to 10, is associated with higher overall congenital anomaly risks including microcephaly, and socioeconomic disparities exacerbate vulnerability through poorer access to healthcare and higher exposure to environmental hazards. Geographically, genetic microcephaly predominates in and the due to higher rates, while infectious causes, especially post-2015 Zika outbreaks, have driven elevated incidence in the . Surveillance efforts by the Centers for Disease Control and Prevention (CDC) and (WHO) track these patterns through population-based systems, though underreporting remains prevalent in developing countries, potentially underestimating true burdens by up to 50% in regions like . As of 2025, Zika-related microcephaly cases have declined globally following the 2016 peak, attributed to reduced transmission and emerging vaccine candidates, though baseline infectious risks persist. Sporadic Zika outbreaks occurred in in 2024, maintaining low-level transmission risks. Concurrently, awareness of (CMV) screening during pregnancy is increasing, as CMV represents a leading preventable infectious cause of microcephaly in non-Zika contexts. In the U.S., congenital CMV newborn screening has been implemented in additional states, including as of July 2025, enhancing early detection of this preventable cause.

Historical Developments and Notable Cases

The medical recognition of microcephaly dates back to the , when German pathologist described cases of reduced cranial capacity accompanied by intellectual impairment, coining the term "microcephalic idiocy" in his 1867 autopsy reports on affected individuals. By the , clinicians began classifying microcephaly into primary (congenital, genetic forms present at birth without progressive degeneration) and secondary (acquired postnatally due to environmental factors or insults) categories, a distinction that facilitated early etiological investigations. In the mid-20th century, environmental links emerged prominently; in 1941, Australian ophthalmologist Norman McAlister Gregg reported the association between maternal infection during early pregnancy and congenital anomalies, including microcephaly, based on observations of 78 cases in , fundamentally altering perceptions of infectious teratogenesis. The 1960s tragedy further illuminated iatrogenic causes, as the , prescribed to pregnant women, resulted in birth defects such as microcephaly in exposed fetuses, prompting global regulatory reforms on drug safety. Modern milestones include the 2002 identification of the MCPH1 gene as the first causative locus for autosomal recessive primary microcephaly, reported by Jackson et al. in a study of consanguineous families from and , ushering in the era of genetic dissection of the disorder. The 2015 Zika virus outbreak in marked a pivotal outbreak-related surge, with the declaring it a Public Health Emergency of International Concern in February 2016 due to its link to microcephaly, following reports of over 4,000 suspected cases by late 2015, which catalyzed international collaborative research. Notable historical cases include William Henry Johnson (c. 1857–1926), known as "Zip the Pinhead," an African American performer in 19th-century American freak shows whose conical head and cognitive features were attributed to microcephaly, exemplifying the era's exploitative public exhibitions of the condition. In contemporary contexts, the Brazilian Zika epidemic yielded significant cohorts, such as the 2015–2016 Pernambuco series of 13 infants with congenital Zika syndrome featuring severe microcephaly, calcifications, and , which informed diagnostic criteria and long-term studies.30902-3/fulltext) Research on microcephaly evolved from 19th–20th century descriptive and epidemiological approaches to in the late 20th and early 21st centuries, with gene discoveries enabling insights into defects. By the 2020s, emphasis shifted toward prevention, including development of maternal vaccines against to mitigate fetal transmission risks, as evidenced by preclinical trials demonstrating protective immunity. The Zika crisis also drove cultural shifts, with awareness campaigns by organizations like the WHO reducing stigma through education on supportive care and family inclusion for affected children.

References

  1. [1]
    Microcephaly | Birth Defects - CDC
    Nov 21, 2024 · Microcephaly is a condition where a baby's head is much smaller than expected. During pregnancy, a baby's head grows because the baby's brain grows.
  2. [2]
    Microcephaly - Symptoms & causes - Mayo Clinic
    Sometimes detected at birth, microcephaly often occurs when there is a problem with brain development in the womb or when the brain stops growing after birth.Overview · Symptoms · When to see a doctor · Causes
  3. [3]
  4. [4]
    Microcephaly - Diagnosis & treatment - Mayo Clinic
    Learn more about microcephaly, when an infant's head is smaller than expected. The condition affects child development.Missing: definition | Show results with:definition
  5. [5]
    Microcephaly - PMC - NIH
    Jun 9, 2017 · Microcephaly is defined as a head circumference more than two standard deviations below the mean for gender and age.
  6. [6]
    Microcephaly Diagnostic Guidelines - Starship Hospital
    Feb 22, 2021 · Microcephaly is defined here as an occipito-frontal circumference (OFC) of greater than 2 SD below the mean for age, sex and ethnicity, which is ...Microcephaly Diagnostic... · Assessment · Investigations
  7. [7]
    Congenital microcephaly: Case definition & guidelines for data ...
    Physiologically, congenital microcephaly is a disorder of reduced brain size and volume resulting from abnormal fetal development. Microcephaly has been ...
  8. [8]
    Diagnostic Algorithm for Microcephaly - Pediatric Neurology Briefs
    Nov 1, 2013 · Serial OFC measurements that follow the growth curve suggest a primary microcephaly, whereas an OFC that falls relative to the growth curve is ...Missing: neuroimaging | Show results with:neuroimaging
  9. [9]
    insights and difficulties in prenatal diagnosis of fetal microcephaly
    Mar 11, 2024 · The prenatal investigation of suspected microcephaly should begin whenever the HC measurement is 2 SD or more below the mean for gestational age ...Abstract · Introduction · False positive diagnosis of... · False negative diagnosis of...
  10. [10]
    Prenatal diagnosis of microcephaly through combined MRI and ...
    Dec 15, 2023 · Ultrasonography (US) is currently the most commonly used imaging modality for detecting microcephaly in the second trimester of pregnancy.
  11. [11]
    Microcephaly in infants and children: Etiology and evaluation
    Oct 10, 2024 · The etiology and evaluation of microcephaly in infants and children will be reviewed here.
  12. [12]
    [PDF] EvALuAtIoN of thE ChILd wIth mICroCEPhALy (AN EvIdENCE ...
    Recommendations are presented for neuroimaging, genetic testing, and screening for coexistent conditions. Please refer to the full guideline at www.aan.com for ...
  13. [13]
    Microcephaly Differential Diagnoses - Medscape Reference
    Jan 21, 2025 · The main differential consideration is to first determine if the patient has craniosynostosis, a problem with brain growth, or no issues beyond head size.Missing: metabolic | Show results with:metabolic
  14. [14]
    [PDF] pediatric newborn medicine clinical practice guidelines
    Oct 26, 2021 · Diagnosis of microcephaly is given if head circumference is less than the 3rd percentile. • Consultation with specialists like a pediatric ...
  15. [15]
    World variation in head circumference for children from birth to 5 ...
    Except for Indians and some Asian neonates, adopting the WHO head circumference standards would overdiagnose macrocephaly and underdiagnose microcephaly.
  16. [16]
    insights and difficulties in prenatal diagnosis of fetal microcephaly
    Mar 12, 2024 · The prenatal investigation of suspected microcephaly should begin whenever the HC measurement is 2 SD or more below the mean for gestational age ...
  17. [17]
    WDR62 Primary Microcephaly - GeneReviews® - NCBI Bookshelf
    Feb 17, 2022 · To date, pathogenic variants in more than 100 genes are known to cause primary microcephaly (for review, see Jayaraman et al [2018]).
  18. [18]
    Autosomal recessive primary microcephaly (MCPH): clinical ...
    Jun 13, 2011 · The ASPM gene at MCPH5 locus and WDR62 at MCPH2 locus have been found mutated in more than 55-60% of the MCPH families jointly, while CDK5RAP2 ...
  19. [19]
    Comprehensive review on the molecular genetics of autosomal ...
    Aug 8, 2018 · The most common causes of MCPH are biallelic mutations in ASPM (68.6%), followed by those in the WDR62 gene (14.1%) and MCPH1 gene (8%).1. Introduction · (i) Mcph1 (microcephalin) · (ii) Mcph2 (wdr62)<|control11|><|separator|>
  20. [20]
    Microcephaly - Breda Genetics
    Dec 25, 2018 · The genes of which mutations cause Seckel syndrome are: ATR, RBBP8, CENPJ, CEP152, CEP63, NIN, DNA2, TRAIP, and NSMCE2. Genetic testing strategy.
  21. [21]
    Rubinstein-Taybi Syndrome - GeneReviews® - NCBI Bookshelf
    Aug 30, 2002 · This condition is caused by missense variants in the last part of exon 30 or the beginning part of exon 31 of CREBBP or the homologous regions ...Missing: Seckel | Show results with:Seckel
  22. [22]
    Rubinstein-Taybi syndrome - Genetics - MedlinePlus
    Mutations in the EP300 gene cause a small percentage of cases of Rubinstein-Taybi syndrome. Like the CREBBP gene, this gene provides instructions for making a ...Missing: microcephaly Seckel
  23. [23]
    De novo POGZ mutations are associated with neurodevelopmental ...
    Seven patients with similar phenotypes of developmental delay and microcephaly were found by whole-exome sequencing to have de novo loss-of-function mutations ...
  24. [24]
    De novo frameshift mutation in ASXL3 in a patient with global ...
    Sep 17, 2013 · We provide additional evidence that, truncating and frameshifting mutations in the ASXL3 gene are the cause of a newly recognized disorder ...
  25. [25]
    Molecular analysis of 23 Pakistani families with autosomal recessive ...
    Oct 27, 2016 · Primary microcephaly is genetically heterogeneous, with most cases showing autosomal recessive inheritance. We designed a panel containing ...
  26. [26]
    Mutations in WDR62 gene in Pakistani families with autosomal ...
    Mutations in WD repeat protein 62 are associated with autosomal recessive primary microcephaly with cortical malformations.
  27. [27]
    Microcephaly, an etiopathogenic vision - ScienceDirect.com
    In 2014, a study reported a genetic or presumed genetic cause in 28.5%, perinatal neurological damage in 27%, craniosynostosis in 2%, postnatal neurological ...
  28. [28]
    Primer on Microcephaly | NeoReviews - AAP Publications
    Jan 1, 2017 · The top 2 reported etiologies for microcephaly in cases with a known underlying diagnosis are genetic disorders and perinatal brain damage ...
  29. [29]
    the molecular mechanisms of primary microcephaly
    Many primary microcephaly mutations occur in genes that encode centrosome proteins, highlighting an important role for centrosomes in cortical development.
  30. [30]
    Same but different: pleiotropy in centrosome-related microcephaly
    Mar 23, 2018 · WDR62 mutants have defective attachment of centrosomes to mitotic spindles, disorganized PCM, abnormal microtubule nucleation, and improper ...Introduction · Fewer Neurons, Smaller Brain · Cpap: Poster Boy For...
  31. [31]
    Autosomal recessive primary microcephaly (MCPH) - PubMed Central
    It has been proposed that mutations in MCPH genes can cause the disease phenotype by disturbing: 1) orientation of mitotic spindles, 2) chromosome condensation ...Do Mcph1, Wdr62 And Aspm... · Genes In Mcph · 1- Microcephalin (mcph1)
  32. [32]
    Relationships between Head Circumference, Brain Volume and ...
    Feb 29, 2016 · These findings confirm group-level reductions in head circumference and increased rates of microcephaly in children with prenatal alcohol exposure.
  33. [33]
    Maternal Smoking During Pregnancy and Offspring Head Growth in ...
    Oct 12, 2021 · Maternal smoking during pregnancy is associated with reduced weight, length and head circumference of the newborn. Postnatally, these ...
  34. [34]
    Antenatal antecedents of a small head circumference at age 24 ...
    Nov 2, 2010 · Tobacco exposure during pregnancy has been associated with an increased risk of congenital microcephaly [33], but we know of no studies ...
  35. [35]
    Radiation Effects on the Fetus - StatPearls - NCBI Bookshelf
    Microcephaly is the most frequently seen manifestation of radiation injury in utero. Diagnostic radiology imaging is essential. It is noted that the risks to ...
  36. [36]
    Prenatal Effects of Antiepileptic Drugs - PMC - NIH
    Exposure to subteratogenic doses of valproic acid can cause microcephaly and behavioral changes (i.e., deficits in spatial learning tasks and altered ...
  37. [37]
    Maternal iodine insufficiency and adverse pregnancy outcomes - PMC
    In China, Cao et al. (1994) reported reduction in the rate of microcephaly from 27% to 11% with iodine repletion of pregnant women with severe iodine ...
  38. [38]
    Cerebral Folate Deficiency Syndrome: Early Diagnosis, Intervention ...
    Jul 28, 2022 · Intrauterine folate deficiency during pregnancy has been associated with neural tube defects ... microcephaly, epilepsy, and cerebral ...
  39. [39]
    Chikungunya virus antepartum transmission and abnormal infant ...
    We found potential statistical associations between maternal CHIKV infection during pregnancy and macerated stillbirth (P = 0.006), microcephaly (P <0.001), ...<|separator|>
  40. [40]
    Early prediction of the development of microcephaly after hypoxic ...
    The development of microcephaly after significant hypoxic-ischemic cerebral injury in the full-term newborn has major prognostic significance.Missing: perinatal asphyxia
  41. [41]
    Factors associated with small head circumference at birth among ...
    Maternal smoking, whether before or during pregnancy, was not associated with microcephaly (Table 2). Similarly, self-reported vaginal bleeding, antepartum ...
  42. [42]
    Developmental Neuropathology of Environmental Agents - PMC
    Such effects may be the result of a direct toxicity of ethanol, of inhibition of neurotrophic properties of glutamate, or of activation of GABA receptors (176).Methylmercury · Lead · Antiepileptic Drugs<|separator|>
  43. [43]
    Thyroid Hypoplasia as a Cause of Congenital Hypothyroidism ... - NIH
    Thyroid Hypoplasia as a Cause of Congenital Hypothyroidism in Monozygotic Twins ... The twins had an unusual dysmorphic facialappearance with microcephaly ...
  44. [44]
    Socioeconomic risk markers of congenital Zika syndrome
    Sep 29, 2022 · The odds of CZS were up to 30% higher comparing live births of women with less than 12 years of education to those with more than 12 years of education.
  45. [45]
  46. [46]
    Time is of the essence: the molecular mechanisms of primary ...
    Many primary microcephaly mutations occur in genes that encode centrosome proteins, highlighting an important role for centrosomes in cortical development.
  47. [47]
    Zika virus NS5 localizes at centrosomes during cell division - PMC
    Zika virus (ZIKV) nonstructural protein 5 (NS5) plays a critical role in viral RNA replication and mediates key virus-host cell interactions.
  48. [48]
    The neurological and non-neurological roles of the ... - Frontiers
    Aspm knockout ferrets showed robust microcephaly, with a reduction in brain weight of around 25–40%.
  49. [49]
    Modeling microcephaly with cerebral organoids reveals a WDR62 ...
    Jun 13, 2019 · Mouse genetic studies suggested that Wdr62 deletion reduces NPCs and leads to a smaller brain size. Wdr62 mutant mice exhibit a mild ...
  50. [50]
    Malformations of Cortical Development - PMC - PubMed Central - NIH
    Disorders of MT formation/function result in multiple brain abnormalities including microcephaly (impaired mitosis); lissencephaly, pachygyria, band ...
  51. [51]
    Congenital Microcephaly with a Simplified Gyral Pattern: Associated ...
    The term “lissencephaly” is used to describe a cortical malformation caused by disturbed neuronal migration. The affected cortex is agyric, and as a result of ...
  52. [52]
    Malformations of cortical development: clinical features and genetic ...
    The malformations of cortical development shown include severe congenital microcephaly with a PMG-like cortical malformation (A), right-sided dysplastic ...
  53. [53]
    Definitions and classification of malformations of cortical development
    Aug 10, 2020 · Microcephaly may have normal or abnormal cortex and may be further classified based on the presence of associated cortical anomalies, such as ...
  54. [54]
    CASK Disorders - GeneReviews® - NCBI Bookshelf
    Nov 26, 2013 · MICPCH is typically seen in females with moderate-to-severe intellectual disability, progressive microcephaly with or without ophthalmologic ...
  55. [55]
    Spectrum of pontocerebellar hypoplasia in 13 girls and boys with ...
    Mar 27, 2012 · Pontocerebellar hypoplasia (PCH) is a heterogeneous group of diseases characterized by lack of development and/or early neurodegeneration of ...Cask Molecular Analysis · Table 2 · Mri FeaturesMissing: deficits | Show results with:deficits
  56. [56]
    Characteristics of Dysphagia in Infants with Microcephaly Caused by ...
    Feeding problems in persons with neurologic diseases are mainly explained by brain damage leading to lack of swallowing coordination; abnormalities of posture; ...
  57. [57]
    Congenital Zika Syndrome and Disabilities of Feeding and ...
    Feb 22, 2023 · Affected infants develop microcephaly and other congenital malformations referred to as congenital Zika syndrome. The neurological ...
  58. [58]
    The “microcephalic hydrocephalus” paradox as a paradigm of ...
    Nov 21, 2023 · Case study of cCMV infection presenting with microcephaly, mild ventriculomegaly, white matter hyperintensities, and sensorineural abnormalities ...
  59. [59]
    Early cranial ultrasound lesions predict head circumference at age 2 ...
    Feb 4, 2016 · We hypothesize that a common final pathway to microcephaly in our ELGAN Study subjects is reduced brain volume due to widespread white matter ...Results · Cranial Sonograms With No... · VentriculomegalyMissing: changes | Show results with:changes
  60. [60]
    Microcephaly in Neurometabolic Diseases - PMC - PubMed Central
    Jan 11, 2022 · Symptoms are caused by the progressive deterioration of mental, motor, and perceptual functions. The authors review the diseases with ...Microcephaly In... · 2.5. Microcephaly, Amish... · 4. Congenital And Acquired...
  61. [61]
    Association of epilepsy with different groups of microcephaly - PubMed
    Overall prevalence of epilepsy was 40.9%. Furthermore, there was a significantly higher prevalence of epilepsy in males. Main seizure type was generalized ...
  62. [62]
    Evaluation of the child with microcephaly (an evidence-based review)
    Sep 15, 2009 · Severe microcephaly would be expected in 0.1% of children if normal distribution is assumed, which agrees with the published estimate of 0.14% ...
  63. [63]
    ASPM Primary Microcephaly - GeneReviews® - NCBI Bookshelf
    Apr 2, 2020 · Syndromic PM, a heterogeneous group in which PM is associated with extracerebral anomalies and growth impairment (e.g., Rubinstein-Taybi ...
  64. [64]
    Intracranial calcifications on CT: an updated review - PMC
    Congenital CMV infection is usually associated with chorioretinitis, microcephaly and IC (6). IC are the most common findings and are seen in 34–70% of ...
  65. [65]
    Microcephaly associated with abnormal gyral pattern - PubMed
    Primary microcephaly is a heterogeneous group of cerebral malformations either with a relatively well-preserved or an abnormal gyral pattern.
  66. [66]
    Predictors of Neurodevelopment in Microcephaly Associated with ...
    Nov 21, 2023 · The long-term outcomes of symptomatic congenital CMV infection show microcephaly in 70%, mental retardation in 61%, hearing loss in 30%, ...
  67. [67]
    Decreased Axon Caliber Underlies Loss of Fiber Tract Integrity ...
    Here, we sought to elucidate the anatomical underpinnings of microcephaly in AS, reasoning that better understanding the causes of impaired brain growth in the ...
  68. [68]
    The neurological and non-neurological roles of the primary ...
    Longitudinal diffusion tensor imaging revealed nerve Fiber alterations in Aspm mutated microcephaly model mice. Neuroscience 371, 325–336. doi: 10.1016/j ...
  69. [69]
    A DTI‐based tractography study of effects on brain structure ...
    We used DTI‐based probabilistic tractography to identify localized regions of WM fiber bundles within three major WM classes: transcallosal tracts (CC, ...
  70. [70]
    Microcephaly | Pediatric Care Online - AAP Publications
    Apr 15, 2021 · Treatment Approach. Treatment is largely supportive, with targeted therapies to address functional disabilities. Refer for early intervention ...
  71. [71]
    Endocrine Dysfunction in Children with Zika-Related Microcephaly ...
    Dec 22, 2020 · About 86% of the children were taking anti-epileptic drugs (AEDs) at the time of the evaluation. These drugs can have endocrine side effects.
  72. [72]
    The efficacy and side effects of levetiracetam on refractory epilepsy ...
    LEV reduced seizure frequency by at least 50% in 58.3% of patients with partial seizures, in 32.0% of patients with primary generalized seizures, and in 17.6% ...
  73. [73]
    Growth Hormone Treatment in Children With Sporadic Primary ...
    Four children with sporadic primary microcephaly associated with short stature, delayed bone age, and low growth velocity are described.
  74. [74]
    Microcephaly Treatment & Management - Medscape Reference
    Jan 21, 2025 · Craniosynostosis warrants consultation with a neurosurgeon and/or craniofacial surgeon, to consider surgery to treat increased intracranial ...
  75. [75]
    Advantages of CRISPR-Cas9 combined organoid model in the study ...
    The results demonstrate that the combination of iPSC-derived brain organoids and CRISPR-Cas9 can exhibit microcephaly pathological features and explain the ...
  76. [76]
    CETN3 deficiency induces microcephaly by disrupting neural stem ...
    Sep 9, 2025 · We showed that CETN3-knockout (KO) organoids successfully recapitulated the microcephaly phenotype of reduced size compared to the control ...
  77. [77]
    Microcephaly | Pediatrics In Review - AAP Publications
    Jul 1, 2025 · Complex craniosynostosis and maternal metabolic disorders have been shown to disrupt brain development, leading to fetal microcephaly that ...
  78. [78]
    Neurological outcome in WDR62 primary microcephaly
    Sep 25, 2021 · Average full-scale IQ was 51.8 (SD 12.6, range 40–70; Fig. 2c). Irrespective of the subtest assessed, we observed interindividual variability ...
  79. [79]
    Developmental Outcomes Among Young Children With Congenital ...
    May 5, 2020 · Almost all children (118 [97.5%]) scored at the standard score floor of 55 on the cognitive domain, with mean score of 55.3 and minimal ...
  80. [80]
    Microcephaly: Symptoms, Causes & Outlook - Cleveland Clinic
    Microcephaly occurs when your baby's head is smaller than expected. Abnormal brain development can cause microcephaly.Missing: differential | Show results with:differential
  81. [81]
    Microcephaly - MedLink Neurology
    Neurologic abnormalities, such as hypotonia, spasticity, seizures, ataxia, tremor, developmental delay, and intellectual disability, may accompany microcephaly.
  82. [82]
    Microcephaly (Concept Id: C4551563) - NCBI
    The facial features may include microcephaly or trigonocephaly / prominent (but not fused) metopic ridge, hypotonic facies with full cheeks, synophrys ...
  83. [83]
    Early Life Epilepsies are a Comorbidity of Developmental Brain ...
    Other factors often seen in general, are nonseizure-related aspiration pneumonia and sepsis, both functions of poor tone, protective reflexes, and mobility.
  84. [84]
    Congenital Zika Syndrome—Assessing the Need for a Family ...
    May 19, 2020 · 78.3% reported drastic life changes, 71.0% reported anxiety, 73.4% reported excellent family support. Personal sacrifice burden score highest.
  85. [85]
    [PDF] Early stimulation for neuropsychomotor development in children with ...
    Objective: To systematically review studies on the effects of early stimulation on the neuropsychomotor development of children with microcephaly.Missing: 2020-2025 | Show results with:2020-2025
  86. [86]
    gaps in long-term care for children with congenital Zika syndrome ...
    Jun 9, 2025 · Sustained, individualized care not only improves child health but also alleviates caregiver burden, enhances quality of life, and may prevent ...
  87. [87]
    Postnatal-Onset Microcephaly: Pathogenesis, Patterns of Growth ...
    Apr 1, 2011 · Microcephaly is a common disorder of childhood with a generally unfavorable prognosis. Most microcephaly is congenital, although some cases ...<|separator|>
  88. [88]
    The Microcephaly Epidemic Research Group Paediatric Cohort ...
    Apr 1, 2021 · This cohort profile aims to describe the ongoing follow-up of children in the Microcephaly Epidemic Research Group Paediatric Cohort (MERG–PC).
  89. [89]
    Study Details | NCT04816175 | Intensive Therapy for Children With ...
    This trial will consist of a clinical series of up to 50 children with Global Developmental Delay and concomitant microcephaly or hyperkinetic movements.
  90. [90]
    Pediatric neurodevelopment by prenatal Zika virus exposure: a ...
    Oct 10, 2020 · The aim of this study is to investigate patterns of neurodevelopment and behavior in groups of children with differening severities of ZIKV-related ...
  91. [91]
    Population-Based Microcephaly Surveillance in the United States ...
    Congenital microcephaly has been associated with other exposures or conditions including placental insufficiency in utero, poorly controlled maternal diabetes, ...
  92. [92]
    Microcephaly Prevalence in Infants Born to Zika Virus-Infected Women
    Aug 5, 2017 · In Europe, estimates point to 1.53 per 10,000 live births (0.02%) [26] and in the USA, 8.7 per 10,000 live births (0.09%) [27]. Therefore, Zika ...Missing: global | Show results with:global
  93. [93]
    Prevalence and diagnostic accuracy of microcephaly in a pediatric ...
    Oct 18, 2020 · During this period, the prevalence of microcephaly was 4.4 per 10,000 live births (5.4 cases per 10,000 live births in Brazil). Other studies ...
  94. [94]
    The genetic epidemiology of the form of microcephaly ascribed to ...
    They state that the incidence of MCPH is ~1 in 10,000 in consanguineous populations and less in non-consanguineous populations. They claim that MCPH2 ...
  95. [95]
    Prevalence and clinical profile of microcephaly in South America pre ...
    Nov 21, 2017 · The association between consanguinity and neural only microcephaly was strong (odds ratio 3.1, 95% confidence interval 1.4 to 7.0) (table 4⇓). ...
  96. [96]
    Brazilian studies highlight Zika microcephaly patterns - CIDRAP
    Jan 16, 2018 · They estimated that 2 to 5 babies per 1,000 live births in Paraiba state had Zika-related microcephaly. They said the high rates of microcephaly ...<|separator|>
  97. [97]
    Increase in Reported Prevalence of Microcephaly in Infants Born to ...
    Mar 11, 2016 · The prevalence of microcephaly in 15 states with laboratory-confirmed Zika virus transmission (2.8 cases per 10,000 live births) significantly ...Missing: global | Show results with:global
  98. [98]
    Articles Risk factors for congenital anomaly in a multiethnic birth cohort
    High levels of educational attainment were associated with reduced risk in all ethnic groups, and advanced maternal age was associated with increased risk.<|separator|>
  99. [99]
    Mapping the risk of Zika virus infections in pregnant persons and ...
    Jul 9, 2025 · The results showed that areas with higher poverty had more cases of Zika in pregnant women and more babies born with microcephaly. This ...Missing: status | Show results with:status
  100. [100]
    Autosomal Recessive Primary Microcephaly (MCPH): A Review of ...
    There are at least seven MCPH loci, and four of the genes have been identified: MCPH1, encoding Microcephalin; MCPH3, encoding CDK5RAP2; MCPH5, encoding ASPM; ...
  101. [101]
    Zika Virus Infection - The New England Journal of Medicine
    Oct 10, 2019 · Panel A shows the number of reported cases of ZIKV infection in the Americas, Pacific Islands, Africa, and Asia, as well as the cumulative.
  102. [102]
    Underreporting of Fatal Congenital Zika Syndrome, Mexico, 2016 ...
    Jul 6, 2019 · We found that an estimated 50% more infants died from microcephaly attributable to congenital Zika syndrome during 2016–2017 than were reported ...
  103. [103]
    PAHO/WHO calls on countries to strengthen surveillance of birth ...
    While the guidelines focus on microcephaly, they will also help countries strengthen their broader responses in relation to congenital defects.Missing: underreporting developing
  104. [104]
    the Latin American Network of Congenital Malformations 2010–2017
    Nov 23, 2021 · This study used data from ReLAMC registries to quantify the prevalence of microcephaly from 2010 to 2017 (before, during and after the Zika virus epidemic).
  105. [105]
    Global burden and incidence trends of zika virus infection among ...
    The ZIKV infection incidence rates in the five SDI regions peaked in 2016 and exhibited a marked increase followed by a decline between 2011 and 2021. The high ...
  106. [106]
    Zika epidemiology update - May 2024
    The map of countries with Zika transmission and list of countries with Zika and vectors has been updated to reflect data as of May 2024.Missing: microcephaly CMV screening
  107. [107]
    Identification of microcephalin, a protein implicated in determining ...
    Primary microcephaly (MIM 251200) is an autosomal recessive neurodevelopmental condition in which there is a global reduction in cerebral cortex volume.Missing: discovery et al paper
  108. [108]
    The Epidemic of Zika Virus–Related Microcephaly in Brazil
    By the end of 2015, 4180 cases of suspected microcephaly had been reported. Zika spread to other American countries and, in February 2016, the World Health ...
  109. [109]
    the exhibition of neurologic disorders at "The Greatest Show on Earth"
    Nov 30, 2010 · More than 20 performers were exhibited as "pinheads," popularly portrayed as "missing links" or children from lost civilizations.Missing: Zip case credible
  110. [110]
    Molecular Genetics of Microcephaly Primary Hereditary: An Overview
    Apr 30, 2021 · Mutations in MCPH1 are the third most frequent cause of MCPH accounting for approximately 8% of the cases [9]. Microcephalin 1 has various ...
  111. [111]
    Current Status of Zika Virus Vaccines: Successes and Challenges
    The recently emerged Zika virus (ZIKV) spread to the Americas, causing a spectrum of congenital diseases including microcephaly in newborn and Guillain-Barré ...